Holen Sie sich die Stockscreener-App
6.29
4.83%
0.29
Handel nachbörslich:
6.15
-0.14
-2.23%
Schlusskurs vom Vortag:
$6.00
Offen:
$6
24-Stunden-Volumen:
56,393
Relative Volume:
0.75
Marktkapitalisierung:
$52.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.92M
KGV:
-12.33
EPS:
-0.51
Netto-Cashflow:
$-18.92M
1W Leistung:
+20.27%
1M Leistung:
-2.48%
6M Leistung:
+152.61%
1J Leistung:
-49.16%
1-Tages-Spanne:
$5.83
$6.37
1-Wochen-Bereich:
$5.01
$6.37
52-Wochen-Spanne:
$1.98
$20.41
Cel-Sci Corp. Stock (CVM) Company Profile
Firmenname
Cel-Sci Corp.
Sektor
Branche
Telefon
703-506-9460
Adresse
8229 Boone Boulevard, Suite 802, Vienna, VA
Vergleichen Sie CVM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVM
Cel-Sci Corp.
|
6.29 | 50.45M | 0 | -26.92M | -18.92M | -0.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cel-Sci Corp. Stock (CVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-01-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-03-02 | Eingeleitet | Dawson James | Buy |
Cel-Sci Corp. Aktie (CVM) Neueste Nachrichten
Cel-sci-sci Corp : Dutton Associates Announces Investment Opinion - marketscreener.com
Cel-Sci (CVM) Reduces R&D Costs and Narrows Net Loss in FY 2025 - GuruFocus
Cancer drug Multikine nears final U.S. trial, seeks Saudi breakthrough status - Stock Titan
CEL SCI CORP SEC 10-K Report - TradingView — Track All Markets
CEL-SCI (NYSE American: CVM) details Multikine survival data and cash outlook - Stock Titan
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Why CEL SCI Corporation stock is rated strong buyWeekly Risk Report & Safe Swing Trade Setups - Улправда
Insider Buying: Geert Kersten Acquires Additional Shares of CEL-SCI Corp (CVM) - GuruFocus
CEL SCI Corp CEO Acquires 8,389 Shares - TradingView — Track All Markets
CEL-SCI Corp (CVM) CEO Geert Kersten reports insider purchase of 8,389 shares - Stock Titan
Can Cel Sci Corporation stock deliver double digit returns2025 Earnings Impact & Safe Capital Allocation Plans - Newser
Will CEL SCI Corporation (LSR) stock gain from lower interest ratesJuly 2025 Analyst Calls & Free Daily Entry Point Trade Alerts - Newser
Will CEL SCI Corporation (LSR) stock attract long term capital inflowsJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - Newser
Is CEL SCI Corporation (LSR) stock resilient in recession scenarios2025 Top Decliners & Community Verified Trade Alerts - Newser
Why CEL SCI Corporation (LSR) stock is upgraded to buy2025 Short Interest & Daily Volume Surge Trade Alerts - Newser
How reliable is Cel Sci Corporation stock dividend growthJuly 2025 Movers & Smart Swing Trading Techniques - Newser
Why Cel Sci Corporation stock is upgraded to buyJuly 2025 Intraday Action & AI Enhanced Execution Alerts - Newser
CEL-SCI (CVM) Stock Analysis Report | Financials & Insights - Benzinga
How CEL SCI Corporation (LSR) stock trades under stagflationJuly 2025 Opening Moves & Technical Pattern Alert System - Newser
Why Cel Sci Corporation stock stays undervaluedEarnings Trend Report & Daily Technical Forecast Reports - Newser
Cel-Sci revises shareholder rights agreement following board approval By Investing.com - Investing.com South Africa
Cel-Sci revises shareholder rights agreement following board approval - Investing.com
CVM Board revises CEL-SCI shareholder rights agreement, files Exhibit 4 - Stock Titan
Why CEL SCI Corporation stock could see breakout soonShort Setup & Real-Time Volume Analysis Alerts - newser.com
Will Cel Sci Corporation stock profit from AI boomQuarterly Investment Review & Fast Moving Trade Plans - newser.com
Is Cel Sci Corporation stock a buy during volatile marketsInflation Watch & Fast Exit and Entry Strategy Plans - newser.com
Why analysts recommend CEL SCI Corporation (LSR) stockJuly 2025 Macro Moves & Smart Allocation Stock Reports - newser.com
Is CEL SCI Corporation stock attractive for hedge fundsTake Profit & Risk Adjusted Buy and Sell Alerts - newser.com
Is Cel Sci Corporation stock protected from inflation2025 Earnings Impact & Step-by-Step Trade Execution Guides - newser.com
What recovery options are there for CEL SCI CorporationTrade Volume Summary & Growth Focused Stock Reports - newser.com
Will CEL SCI Corporation stock benefit from upcoming earnings reports2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
How Cel Sci Corporation stock expands through international marketsQuarterly Earnings Summary & Long-Term Safe Investment Ideas - newser.com
Why CEL SCI Corporation (LSR) stock is listed among top recommendationsJuly 2025 Highlights & Technical Entry and Exit Alerts - newser.com
Is Cel Sci Corporation stock prepared for digital transition2025 Big Picture & AI Powered Trade Plan Recommendations - newser.com
How rising interest rates impact CEL SCI Corporation stockMarket Sentiment Summary & Consistent Growth Equity Picks - newser.com
Why Cel Sci Corporation stock is trending on social mediaTrade Entry Report & Weekly Momentum Picks - newser.com
Why CEL SCI Corporation (LSR) stock appeals to dividend investorsBull Run & Consistent Return Strategy Ideas - newser.com
What insider purchases suggest about Cel Sci Corporation stockGap Up & High Yield Stock Recommendations - newser.com
How CEL SCI Corporation stock reacts to bond yields2025 Market Overview & Real-Time Volume Analysis Alerts - newser.com
Is CEL SCI Corporation stock attractive for income investorsExit Point & Intraday High Probability Setup Alerts - newser.com
Finanzdaten der Cel-Sci Corp.-Aktie (CVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):